| 000 | 01826 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514023138.0 | ||
| 264 | 0 | _c20020304 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1067/mcp.2002.121217 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobertson, Philmore | |
| 245 | 0 | 0 |
_aEffect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cJan 2002 |
||
| 300 |
_a46-56 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aBenzhydryl Compounds _xadverse effects |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 |
_aCentral Nervous System Stimulants _xadverse effects |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aEstradiol Congeners _xadverse effects |
| 650 | 0 | 4 |
_aEthinyl Estradiol _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGas Chromatography-Mass Spectrometry |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xadverse effects |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xmetabolism |
| 650 | 0 | 4 | _aModafinil |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 650 | 0 | 4 |
_aTriazolam _xadverse effects |
| 700 | 1 | _aHellriegel, Edward T | |
| 700 | 1 | _aArora, Sanjay | |
| 700 | 1 | _aNelson, Michael | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 71 _gno. 1 _gp. 46-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1067/mcp.2002.121217 _zAvailable from publisher's website |
| 999 |
_c11733415 _d11733415 |
||